Management of Early Parkinson's Disease - Oxford American Pocket Notes (Spiral bound)
  • Management of Early Parkinson's Disease - Oxford American Pocket Notes (Spiral bound)
zoom

Management of Early Parkinson's Disease - Oxford American Pocket Notes (Spiral bound)

(author), (author)
£6.99
Spiral bound Published: 04/02/2010
  • Not available

This product is currently unavailable.

  • This item has been added to your basket
Parkinson's Disease (PD) is a progressive, neurodegenerative disorder with the cardinal symptons of bradykinesia, rigidity and tremor, as well as a postural inability in the later stages of the disease. It has been estimated that over 1,000,000 people in the United States are affected by PD with approximately 50,000-60,000 new cases diagnosed each year. The average age of PD onset is 60 years, although persons can onset much later and approximately 4-10% onset prior to the age of 40. The primary neurochemical change in PD is a loss of dopamine in the substantia niger, although it is increasingly recognized that additional neurotransmitters and brain areas are involved. The cause of PD is unknown, and there is currently no cure available. The treatment of PD can be challenging and treatment of early PD can be complex with choice of initial therapy, as well as timing the initiation of therapy. Although there are currently no treatments approved to stop or slow the progression of PD, this is an area of active research, as it is estimated that approximately 60-80% of dopamine neurons are lost by the time of diagnosis. There are several symptomatic treatments available for all stages of PD, including monoamine oxidase type B (MAO-B) inhibitors, dopamine agonists, levodopa, and less commonly, anticholinergics and amantadine. The treatment regimen in the early stage needs to be individualized based on the disease characteristics and life situation of each patient. The goal of therapy in early PD is to identify a treatment strategy to control the parkinsonian symptons, such as motor fluctuations and dyskinesia, without causing adverse events.

Publisher: Oxford University Press Inc
ISBN: 9780195386493
Weight: 55 g
Dimensions: 171 x 101 x 10 mm

You may also be interested in...

Schema Therapy
Added to basket
£35.99
Paperback
Awakenings
Added to basket
£10.99
Paperback
Bipolar Disorder
Added to basket
£12.99
Paperback
The Female Brain
Added to basket
Understanding Autism For Dummies
Added to basket
Neuroscience
Added to basket
£40.95
Hardback
The Human Brain
Added to basket
I Had a Black Dog
Added to basket
The Master and His Emissary
Added to basket
Dementia: The One-Stop Guide
Added to basket
Depressive Illness
Added to basket
Malignant Sadness
Added to basket
£9.99
Paperback
The Complete Guide to Asperger's Syndrome
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.